Show
Sort by
-
Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer
-
Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer
-
- Journal Article
- A2
- open access
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
-
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)
-
Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study
-
Preoperative chemosensitivity testing as predictor of adjuvant benefit in stage III colon